» Articles » PMID: 33604180

Vitamin C Supplementation Reduces Expression of Circulating MiR-451a in Subjects with Poorly Controlled Type 2 Diabetes Mellitus and High Oxidative Stress

Overview
Journal PeerJ
Date 2021 Feb 19
PMID 33604180
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitamin C is an essential element required for normal metabolic function. We investigated the effect of vitamin C supplementation on circulating miRNA (miR) expression in subjects with poorly controlled type 2 diabetes mellitus (T2DM). Changes in miR expression were also correlated with clinical measures of disease.

Methods: Pre- and post-vitamin C supplementation samples from five participants who had increased vitamin C levels, improved oxidative status and polymorphonuclear (PMN) function after receiving 1,000 mg of vitamin C daily for six weeks were screened for miRNA expression using the NanoString miRNA assay. Differences in miRNA expression identified from the miRNA screen were validated by qRT-PCR.

Results: Four miRNAs showed significantly different expression post-vitamin C supplementation relative to baseline, including the down-regulation of miR-451a (-1.72 fold change (FC),  = 0.036) and up-regulation of miR-1253 (0.62 FC,  = 0.027), miR-1290 (0.53 FC,  = 0.036) and miR-644a (0.5 FC,  = 0.042). The validation study showed only miR-451a expression was significantly different from baseline with vitamin C supplementation. MiR-451a expression was negatively correlated with vitamin C levels ( =  - 0.497,  = 0.049) but positively correlated with levels of malondialdehyde (MDA) ( = 0.584,  = 0.017), cholesterol ( = 0.564,  = 0.022) and low-density lipoproteins (LDL) ( = 0.522,  = 0.037). Bioinformatics analysis of the putative target genes of miR-451a indicated gene functions related to signaling pathways involved in cellular processes, such as the mammalian target of rapamycin (mTOR) signaling pathway.

Conclusions: Vitamin C supplementation altered circulating miR-451a expression. The results from this pilot study suggest that miRNAs could be used as biomarkers to indicate oxidative status in subjects with T2DM and with poor glycemic control and could lead to a novel molecular strategy to reduce oxidative stress in T2DM.

Citing Articles

MicroRNA-451a downregulation in liraglutide-treated individuals with diabetes: A potential cardiovascular protective mechanism.

Kongrat S, Sungkaworn T, Muanprasat C, Sriphrapradang C, Yingchoncharoen T Diab Vasc Dis Res. 2024; 21(5):14791641241278527.

PMID: 39325062 PMC: 11437537. DOI: 10.1177/14791641241278527.


Vitamin C supplementation lowers advanced glycation end products (AGEs) and malondialdehyde (MDA) in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial.

Rabizadeh S, Heidari F, Karimi R, Rajab A, Rahimi-Dehgolan S, Yadegar A Food Sci Nutr. 2023; 11(10):5967-5977.

PMID: 37823170 PMC: 10563761. DOI: 10.1002/fsn3.3530.


Connection between Radiation-Regulating Functions of Natural Products and miRNAs Targeting Radiomodulation and Exosome Biogenesis.

Tang J, Chuang Y, Shiau J, Yen C, Chang F, Tsai Y Int J Mol Sci. 2023; 24(15).

PMID: 37569824 PMC: 10419287. DOI: 10.3390/ijms241512449.


The Effect of β-Carotene, Tocopherols and Ascorbic Acid as Anti-Oxidant Molecules on Human and Animal In Vitro/In Vivo Studies: A Review of Research Design and Analytical Techniques Used.

Miazek K, Beton K, Sliwinska A, Brozek-Pluska B Biomolecules. 2022; 12(8).

PMID: 36008981 PMC: 9406122. DOI: 10.3390/biom12081087.


EndMT Regulation by Small RNAs in Diabetes-Associated Fibrotic Conditions: Potential Link With Oxidative Stress.

Giordo R, Ahmed Y, Allam H, Abusnana S, Pappalardo L, Nasrallah G Front Cell Dev Biol. 2021; 9:683594.

PMID: 34095153 PMC: 8170089. DOI: 10.3389/fcell.2021.683594.

References
1.
Ranjan R, Lee Y, Karpurapu M, Syed M, Chung S, Deng J . p47phox and reactive oxygen species production modulate expression of microRNA-451 in macrophages. Free Radic Res. 2014; 49(1):25-34. PMC: 4360955. DOI: 10.3109/10715762.2014.974037. View

2.
He Y, Ding Y, Liang B, Lin J, Kim T, Yu H . A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus. Int J Mol Sci. 2017; 18(3). PMC: 5372489. DOI: 10.3390/ijms18030456. View

3.
Turchinovich A, Tonevitsky A, Burwinkel B . Extracellular miRNA: A Collision of Two Paradigms. Trends Biochem Sci. 2016; 41(10):883-892. DOI: 10.1016/j.tibs.2016.08.004. View

4.
Jimenez-Lucena R, Rangel-Zuniga O, Alcala-Diaz J, Lopez-Moreno J, Roncero-Ramos I, Molina-Abril H . Circulating miRNAs as Predictive Biomarkers of Type 2 Diabetes Mellitus Development in Coronary Heart Disease Patients from the CORDIOPREV Study. Mol Ther Nucleic Acids. 2018; 12:146-157. PMC: 6023857. DOI: 10.1016/j.omtn.2018.05.002. View

5.
Kuwabara Y, Horie T, Baba O, Watanabe S, Nishiga M, Usami S . MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway. Circ Res. 2014; 116(2):279-88. DOI: 10.1161/CIRCRESAHA.116.304707. View